Vaccines

Millions of doses of Pfizer Inc (NYSE: PFE) and BioNTech SE’s  (NASDAQ: BNTX) COVID-19 vaccine will be administered in China alongside home-made options, Bloomberg reported Tuesday. What Happened: Local pharmaceutical firm Shanghai Fosun Pharmaceutical (Group) Co, Ltd (OTC: SFOSF)...

Moderna Inc (NASDAQ: MRNA) said documents related to its COVID-19 vaccine were targeted by hackers in an attack on the European Medicines Agency (EMA), Reuters reported Monday. What Happened: The Cambridge, Massachusetts-based vaccine maker said its submissions to the EMA didn't contain any...

Now that the vaccine from Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) has been given the greenlight from the U.S. Food and Drug Administration, the companies have to scale up rapidly to meet demand. Why It Matters: BioNTech CEO Ugur Sahin in an interview with...

Even as emergency use authorization came in late Friday for the COVID-19 vaccine from Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) announced a greater committment from the U.S. for its vaccine candidate, mRNA-1273. What Happened:...

Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NYSE: GSK) on Friday reported a delay in their COVID-19 vaccine program as interim results from Phase 1 and 2 trials indicate a low immune response in older adults. What Happened: The drugmakers said in a statement that early-stage vaccine trials...

Pfizer Inc (NYSE: PFE and BioNTech SE (NASDAQ: BNTX) have got the green light on their COVID-19 vaccine from an external panel of experts that advise the United States Food and Drug Administration. What Happened: The Vaccines and Related Biological Products Advisory Committee (VRBPAC)...

Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said on Wednesday that hackers illegally accessed documents related to their COVID-19 vaccine in an attack on the European Medicines Agency (EMA). What Happened: The two companies said in a statement they believe the...

The United Kingdom will administer one shot each of COVID-19 vaccines made by Pfizer Inc (NYSE: PFE) and AstraZeneca plc (NASDAQ: AZN) to test whether the approach would result in increased immunity, Bloomberg reported Monday. What Happened: The studies planned for the next year, will be...

Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates said that nearly half a dozen vaccines from different manufacturers could be available by the spring of 2021, CNBC reported Tuesday. What Happened: “I expect that we’ll have about six vaccines approved by the first quarter,...

Pfizer Inc (NYSE: PFE) has told the outgoing Donald Trump administration that it cannot supply a considerable amount of additional doses of its COVID-19 vaccine to the United States until late June because other countries have hastened to secure the supply, the Washington Post reported Monday. What...

A member of a United States Food and Drug Administration committee on vaccines said that the agency could issue an emergency authorization for Pfizer Inc’s (NYSE: PFE) COVID-19 vaccine as early as Friday. What Happened: James Hildreth, a member of the Vaccines and Related Biological Products...

AstraZeneca Plc’s  (NASDAQ: AZN) partner, the Serum Institute of India, applied for emergency use authorization of the former's COVID-19 vaccine candidate on Sunday, as per the Press Trust Of India. What Happened: The SII is conducting the phase-3 clinical trial of the...

Moderna Inc (NASDAQ: MRNA) expects to make 100 million to 125 million doses of its COVID-19 vaccine available worldwide in the first quarter of 2021. What Happened: The Cambridge, Massachusetts-based company affirmed Thursday in a statement that out of the doses slated for Q1, 85-100 million...

Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Wednesday they have received regulatory approval in the United Kingdom for their COVID-19 vaccine. What Happened: The go-ahead from the Medicines and Healthcare Products Regulatory Agency (MHRA) means the U.K. has...

Over six million doses of Pfizer Inc’s  (NYSE: PFE) COVID-19 vaccine could be distributed within 24 hours of it being given the go-ahead by the United States Food And Drug Administration, The Washington Post reported Tuesday. What Happened: The vaccine’s 6.4 million doses would be...